Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-24T21:23:15.006Z Has data issue: false hasContentIssue false
  • English
  • Français

Identification and Voluntary Reduction of Vancomycin Use for Perioperative Antibiotic Prophylaxis During Coronary Artery Bypass Graft Surgery

Published online by Cambridge University Press:  02 January 2015

Suzanne M. Pear ,
Deborah L. Goldsmith ,
Theresa H. Williamson ,
David Mandel ,
Gulshan K. Sethi ,
David A. Arzouman  and
Neil M. Ampel
Deborah L. Goldsmith
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
Theresa H. Williamson
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
David Mandel
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
Gulshan K. Sethi
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
David A. Arzouman
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
Neil M. Ampel*
Affiliation:
Medical and Cardiothoracic Surgery Services of the Tucson Veterans' Affairs Medical Center and the Departments of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona
*
Medical Service (111), VAMC, 3601 S Sixth Ave, Tucson, AZ 85723; e-mail, nampel@u.arizona.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Vancomycin prophylaxis for coronary artery bypass graft surgery without prosthetic valve implantation voluntarily decreased from 94% to 18% in one medical center. Median hospital stay (10 vs 9 days, P=.30) and number of postoperative infections (17.0% vs 14.3%, P=.60) did not differ among patients who received vancomycin and those who did not.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 7 , July 1998 , pp. 513 - 515
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance—report from the Hospital Infection Control Practices Advisory Committee. Federal Register 1994;59:25758–25763.Google Scholar
2.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA 1988;263:961–966.Google Scholar
3.Horan, TC, Gaynes, RP, Martone, WJ, Emori, TG. CDC definitions for nosocomial surgical site infections, 1992. A modification of CDC definitions of surgical wound infections. Am J Infect Control 1992;20:271–274.Google Scholar
4.Sokal, RR, Rohlf, FJ. Biometry. The Principles and Practice of Statistics in Biological Research. New York, NY: W.H. Freeman and Co; 1995.Google Scholar
5.Pestotnik, SL, Classen, DC, Evans, RS, Burke, JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884–890.Google Scholar
6.Goldmann, DA, Weinstein, RA, Wenzel, RP, Tablan, OC, Duma, RJ, Gaynes, RP, et al.Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAAMA 1996;275:234–240.Google Scholar
7.Maki, DG, Bohn, MD, Stolz, SM, Kroncke, GM, Acher, CW, Myerowitz, PD. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. J Thorac Cardiovasc Surg 1992;104:1423–1434.Google Scholar
8.Ranson, MR, Oppenheim, BA, Jackson, A, Kamthan, AG, Scarffe, JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15:95–102.Google Scholar